Cargando…
The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancer
BACKGROUND: Colorectal cancer is a heterogeneous disease with complex genetic and epigenetic changes. LncRNA has recently been regarded as the biomarker in cancers. Novel biomarkers in colon cancer need to be identified. PURPOSE: The objective of this study was to identify the differentially express...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643096/ https://www.ncbi.nlm.nih.gov/pubmed/31410022 http://dx.doi.org/10.2147/OTT.S215419 |